Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Midday Movers: Biogen, Apple, DocuSign and More

Published 28/09/2022, 18:52
Updated 28/09/2022, 18:52
© Reuters.

By Liz Moyer

Investing.com -- U.S. stocks rose after the Bank of England stepped in to stabilize the British pound. Here are the midday movers for Sept. 28:

  • Biogen Inc (NASDAQ:BIIB) shares jumped 37% after its drug making partner Eisai Co (OTC:ESALY)., Ltd. (TYO:4523) reported a successful late-stage trial of their Alzheimer's drug, saying it reduced cognitive decline by 27% in patients. Eisai's shares jumped 62%. Eli Lilly and Company (NYSE:LLY), which is also working on a treatment, rose 8%.
  • Apple Inc (NASDAQ:AAPL) shares fell 2.3% after a report it decided not to increase the production of its newest iPhone but hold to earlier production levels.
  • DocuSign Inc (NASDAQ:DOCU)shares rose 4.7% after the electronic signature company said it was cutting 9% of its workers, eyeing a $40 million charge for restructuring.
  • VF Corporation (NYSE:VFC) shares fell 3% after it cut guidance, citing lower sales of its Vans casual shoes and North Face apparel.
  • Thor Industries Inc (NYSE:THO) shares rose 3.7% after the RV maker beat fourth quarter expectations. It did see demand could be an issue going forward after a pandemic craze for buying RVs.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.